DossierENTITY

Tempus AI

Coverage of Tempus AI in the Nexus archive.

Earliest in view: Jul 21 · 12:40 UTCMost recent: Jul 21 · 12:40 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJul 21 · 12:40 UTCQUARTZ
Tempus AI is acquiring cancer-monitoring firm Personalis in a $1.5 billion stock deal
Tempus AI is acquiring cancer-monitoring firm Personalis in a $1.5 billion all-stock deal. The transaction grants Tempus control of Personalis' NeXT Personal cancer detection test.